Stay updated with breaking news from Dror Ben Asher. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RedHill Biopharma Reports Operational Highlights and Third Quarter 2021 Financial ResultsRedHill Accelerates its Two Advanced COVID-19 Pill Clinical Programs in Light of their Potential Against OmicronActing
RedHill Accelerates its Two Advanced COVID-19 Pill Clinical Programs in Light of their Potential Against Omicron Acting independently of spike protein...
Dror Ben-Asher, RedHill's chief executive officer commented: "Our US commercial business continues to drive growth, delivering a second...
RESEARCH TRIANGLE PARK - RedHill Biopharma is reporting a 62% reduction in mortality for severe COVID-19 patients using its investigational oral pill-based
Investegate announcements from RedHill Biopharma, 62% COVID19 Mortality Reduction with Oral Opaganib